Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
about
Managing aromatase inhibitors in breast cancer survivors: not just for oncologistsThe advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.Is tamoxifen alone adequate therapy in very young Chinese women with operable breast cancer?Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer
P2860
Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
@en
Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
@nl
type
label
Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
@en
Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
@nl
prefLabel
Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
@en
Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
@nl
P2093
P50
P1433
P1476
Adjuvant endocrine therapy for perimenopausal women with early breast cancer
@en
P2093
Eduard Vrdoljak
Hans Wildiers
J Michael Dixon
Jean-Philippe Spano
Nicolai Maass
Olaf Ortmann
Olivia Pagani
Tanja Cufer
P356
10.1016/J.BREAST.2008.10.002
P577
2008-11-26T00:00:00Z